Rapamune
Submitted by Anonymous (not verified) on 19 September 2025 - 8:40
Rapamune
Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals European Commission final decision, 22/08/2025, 19/09/2025
Submitted by Anonymous (not verified) on 19 September 2025 - 7:00
Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals European Commission final decision, 22/08/2025, 19/09/2025
Human medicines European public assessment report (EPAR): Zonegran, zonisamide, Date of authorisation: 10/03/2005, Revision: 37, Status: Authorised
Submitted by Anonymous (not verified) on 18 September 2025 - 16:02
Human medicines European public assessment report (EPAR): Zonegran, zonisamide, Date of authorisation: 10/03/2005, Revision: 37, Status: Authorised
Visudyne
Submitted by Anonymous (not verified) on 18 September 2025 - 15:22
Visudyne
ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 09:30 (CET) to 20 February 2025, 14:00 (CET)
Submitted by Anonymous (not verified) on 18 September 2025 - 11:34
ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 09:30 (CET) to 20 February 2025, 14:00 (CET)
Management Board meeting dates 2026-2027
Submitted by Anonymous (not verified) on 18 September 2025 - 11:28
Management Board meeting dates 2026-2027
Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 8 September 2025, 11:00 (CEST) to 8 September 2025, 12:00 (CEST)
Submitted by Anonymous (not verified) on 18 September 2025 - 11:23
Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 8 September 2025, 11:00 (CEST) to 8 September 2025, 12:00 (CEST)
Cancer Medicines Forum: June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 June 2025, 14:00 (CEST) to 17 June 2025, 17:00 (CEST)
Submitted by Anonymous (not verified) on 18 September 2025 - 11:18
Cancer Medicines Forum: June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 June 2025, 14:00 (CEST) to 17 June 2025, 17:00 (CEST)
Overview of Network Data Steering Group (NDSG) change management activities 2025-2026
Submitted by Anonymous (not verified) on 18 September 2025 - 9:01
Overview of Network Data Steering Group (NDSG) change management activities 2025-2026
Letter of intent for the submission of a worksharing procedure to the European Medicines Agency according to Article 65 of Regulation (EU) 2019/6
Submitted by Anonymous (not verified) on 17 September 2025 - 16:02
Letter of intent for the submission of a worksharing procedure to the European Medicines Agency according to Article 65 of Regulation (EU) 2019/6